To study limphocyte subpopulation changes in chimeric and humanised b-cell depleting antibodies for multiple sclerosis
Latest Information Update: 13 Jan 2020
At a glance
- Drugs Ocrelizumab (Primary) ; Rituximab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
Most Recent Events
- 13 Jan 2020 New trial record